⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
保険業界のAIの先陣を切るmea Platform、SEPから5,000万米ドルのグロース・エクイティによる資金調達、業界のコンバインド・レシオ改善と利益率向上へ
businesswire.com
AXS
CNA
MRK
SCOR
ACGL
保險AI領軍企業mea Platform從SEP融資5000萬美元成長股權，協助改善產業綜合成本率和利潤率
businesswire.com
AXS
CNA
MRK
SCOR
ACN
DXC
NOW
VRSK
保險AI領軍企業mea Platform從SEP融資5000萬美元成長股權，協助改善產業綜合成本率和利潤率
businesswire.com
AXS
CNA
MRK
VRSK
保险AI领军企业mea Platform从SEP融资5000万美元增长股权，助力改善行业综合成本率和利润率
businesswire.com
AXS
CNA
MRK
ACN
DXC
NOW
VERI
保险AI领军企业mea Platform从SEP融资5000万美元增长股权，助力改善行业综合成本率和利润率
businesswire.com
AXS
CNA
MRK
ACN
DXC
NOW
VERI
Growth Factors Market to Reach US$ 3.7 Bn by 2033, Expands Amid Rising Regenerative Medicine and Biopharmaceutical Innovation - Persistence Market Research
prnewswire.com
TMO
MRK
BIO
BIIB
AMGN
GILD
REGN
CRSP
NTLA
BMY
ABBV
AZN
NVS
PFE
JNJ
MRNA
BNTX
COR
STEM
ALGN
EXAS
MDLZ
BHC
CVS
UNH
CI
CNC
ELAN
ZTS
ISRG
QRVO
SWKS
AVGO
QCOM
INTC
MSFT
GOOG
AMZN
IBM
ORCL
CRM
ADBE
NFLX
DIS
MCD
SBUX
KO
PEP
PG
JPM
BAC
WFC
C
GS
MS
AXP
V
MA
HD
LOW
COST
TGT
WMT
BBY
CMCSA
VZ
T
XOM
CVX
SIRI
UBER
LYFT
NVDA
AMD
MU
AMAT
LRCX
ASML
ADI
TXN
QGEN
ILMN
VRTX
EDIT
BEAM
SRPT
ACAD
ALKS
MDT
SYK
DHR
GOOGL
U.S. Orphan Drug Market Report 2026: A $200 Billion Opportunity by 2031 - Indication, Company, Trial Phase, Marketed Status of 1400 Drugs, Drug Sales of 150 Drugs, Pricing and Dosage of 400 Drugs
globenewswire.com
BMY
GILD
JNJ
SNY
TAK
AMGN
AZN
LLY
MRK
PFE
REGN
VRTX
ABBV
ALNY
AMTX
BIIB
BMRN
CRSP
EXAS
INCY
IONS
JAZZ
NTLA
PTC
RGEN
XOM
Insurance AI Leader mea Platform Targets Industry Combined Ratios and Margins With a $50 Million Growth Equity Raise From SEP
businesswire.com
AXS
CNA
MRK
VRSK
Insurance AI Leader mea Platform Targets Industry Combined Ratios and Margins With a $50 Million Growth Equity Raise From SEP
businesswire.com
AXS
CNA
MRK
ACN
DXC
NOW
VERI
Poxel Reports its 2025 Revenue and Provides an Update on its Financial Position
businesswire.com
MRK